3PBI Pharma Unit · Market Intelligence

Business intelligence and AI for the pharmaceutical industry

A full managed market-reporting service with applied AI. We integrate market, prescription, social-security and distributor data into a single source of truth, and generate actionable insights for every area of your laboratory.

Elea Bagó Laboratorios Bernabó AbbVie Bristol Myers Squibb Novo Nordisk Novartis Servier Sanofi Roche
A full managed reporting service

Integrated data, actionable insights

A continuous process that turns scattered market data into reliable, action-ready information.

01

Collection

Multiple sources provided or enabled by the laboratory.

02

Cleansing

Standardization and quality control at every stage.

03

Integration

A single, powerful and consistent data model.

04

Publishing

Interactive online reports — responsive and collaborative.

05

AI Insights

Findings, projections and actionable explanations generated with AI on top of the model.

06

Support

Analysis, KPI tracking and continuous improvement.

Data integration

Key data sources

The retail and specialty markets draw on different sources: we integrate them into a single model.

Retail
IQVIA / IMSClose-UpFarmalinkFarmalabPreserfarPAMIAlfabeta
Specialty · Onco
DistributorsCAMOyTEFarmaliveDADSEIQVIAOthers
Transversal
Salesforce / CRMERP / SharePointFinance
Single source of truth
Data Model
All sources, integrated and consistent, updated daily.
Role-based online reports
Interactive, responsive and always available.
AI Insights
Findings and projections on your own model.
KPIs & alerts
Geared to immediate action.
Market intelligence modules

A solution for every need

Our modular structure adapts to what each laboratory requires.

Retail

Market, prescriptions, social security and pricing

SOURCES · IQVIA · Close-Up · Farmalink · Farmalab · Preserfar · Alfabeta

Market Audit

Market-share comparisons and trends by active ingredient, segment and region.

IQVIA / IMS

Prescriptions by Physician

Call effectiveness, prescription share and non-visited prescribers, by specialty and location.

CLOSE-UP

Social Security & Agreements

Settlements by agreement, with and without competition. Performance by entity, product and drug.

FARMALINK · FARMALAB · PRESERFAR

PAMI Report

Performance in the PAMI market with detail by prescriber, specialty and location.

FARMALINK + CLOSE-UP

Public Pricing

National and international price comparisons, trends, dispersion and variations.

ALFABETA / KAIROS

Promotional Activity

Vouchers, patient programs and promotional activity at the point of sale.

PRIVATE CHANNEL · PHARMACIES
Specialty · Onco

Oncology and special treatments

SOURCES · Distributors · CAMOyTE · Farmalive · DADSE

Distributors / Patient Deliveries

Fulfilled-delivery prescriptions by product, physician and patient. New / Switch / Drop patients, forecast and Key Influencers with AI.

DISTRIBUTORS

Oncology Agreements (Onco)

Modeling of the industry’s collective agreements to track the laboratory’s share by market.

CAMOyTE

Authorizations & Tenders

Authorizations and replenishments, and tracking of high-cost public-sector tenders.

FARMALIVE · DADSE
Transversal

Apply to both segments

on the same data model

Finance Reconciliation

Contribution audit: accounting records vs. agents’ settlements. Detects deviations, gaps and data-entry errors.

DAILY / WEEKLY PROCESS

Finance & Economics

The laboratory’s margins, volumes and profitability integrated into the same data model.

LABORATORY DATA
Secure, role-based access

Farmatecnia Platform

All your market information, anytime and anywhere — with no per-user licenses.

A dedicated, hosted and secure site with role-based access. Each user sees their own scope of information, with no per-seat license cost.

  • 100% responsive: desktop, tablet and mobile
  • Multiple, role-differentiated access
  • Periodic updates with user notifications
  • Hosted on a dedicated server, with no infrastructure on the laboratory’s side
  • KPIs and alerts geared to immediate action
AI Insights

Market analysis generated with AI

On the same integrated model, it generates actionable findings in plain language.

✦ AI-generated report Market economic read integrated model
Prices
Class price adjustment +4.2% vs. prior quarter

The category rose above inflation; your portfolio ended 1.1 pp above the market’s average price.

Margins
Estimated portfolio margin +0.8 pp

The shift toward higher-value presentations improves profitability without giving up volume.

Volumes
Units +6% YoY

Sustained growth, with a slowdown in the public channel due to collection delays at PAMI.

Threat
Pressure on the average price −3.1 pp share

A competitor is gaining ground via discounts at AMBA distributors and pressuring the category.

Opportunity
Projected revenue at year-end

The price–volume mix in high-potential segments projects a revenue improvement toward year-end.

✦ Generated with AI on the integrated model — explained in plain language for every area of the laboratory.
Direct benefits

The impact on your commercial team

Responsive support for Commercial Planning and Product/District Managers
Results-oriented KPIs, measurable and published periodically
Opportunity identification for the Sales Force
Insight into competitors’ moves
Better estimation of margins and volumes
Greater visibility into what impacts profitability
Active tracking of commercial actions, results and trends
End-to-end delegation of reporting processes
Reliable, periodic information for decision-making
What our clients say

“They don’t deliver generic reports: they first understand the business and the KPIs, and that’s why the results are outstanding.”

— Commercial Manager, leading laboratory
Book a meeting

Discover our portfolio

Tell us what you need to measure and we’ll show you cases and sample reports from leading laboratories.

info@3pbiconsulting.com